Showing results (2531-2540 of 6,740) with videos related to
Sort By:
Pageof 674
Oncotargets and Therapy|April 10, 2013
Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancerXuejun Dong, Mingfeng Yang, He Sun, et al.Oncotargets and Therapy|April 27, 2013
A brief review of different types of sweat-gland carcinomas in the eyelid and orbitLeilei Zhang, Shengfang Ge, Xianqun FanOncotargets and Therapy|April 27, 2013
Cytotoxic effects of bromelain in human gastrointestinal carcinoma cell lines (MKN45, KATO-III, HT29-5F12, and HT29-5M21)Afshin Amini, Anahid Ehteda, Samar Masoumi Moghaddam, et al.Oncotargets and Therapy|April 17, 2013
Update of research on the role of EZH2 in cancer progressionLiang Shen, Jing Cui, Shumei Liang, et al.Oncotargets and Therapy|March 16, 2013
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLCValerie Nelson, Jacqueline Ziehr, Mark Agulnik, et al.Oncotargets and Therapy|March 16, 2013
Novel Bruton's tyrosine kinase inhibitors currently in developmentOsmond J D'Cruz, Fatih M UckunOncotargets and Therapy|April 13, 2013
Treatment results of incomplete chemoradiotherapy in locally advanced cervical cancerYing Gao, Fei Gao, Zi Liu, et al.Oncotargets and Therapy|February 14, 2013
Stereotactic body radiation therapy via helical tomotherapy to replace brachytherapy for brachytherapy-unsuitable cervical cancer patients - a preliminary resultChen-Hsi Hsieh, Hui-Ju Tien, Sheng-Mou Hsiao, et al.Oncotargets and Therapy|February 5, 2013
Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancerRavit Geva, Loredana Vecchione, Sabine Tejpar, et al.Oncotargets and Therapy|November 28, 2012
γ-H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancerDimitrios Matthaios, Periklis G Foukas, Maria Kefala, et al.Pageof 674